V5 Ultimate
Ultimate
PricingResourcesCompany
Start free trial
HomeGlossaryBotanical Extract Characterization
Lab · The complete guide

Botanical Extract Characterization

In short

Botanical extract characterization is the technical regime that distinguishes 'standardised extract' (single marker compound at declared %, e.g. milk thistle 80% silymarin) from 'full-spectrum extract' (declared by drug-to-extract ratio, e.g. 4:1 DER, with multi-marker chromatographic profile).

Read the full summary

Under 21 CFR 111.75(a)(1)(i) every botanical component lot must be identity-verified — but identity for a complex botanical extract is more than species confirmation. It includes marker assay, solvent residual, foreign-material screening, and (for premium products) HPTLC chromatographic fingerprint comparison to a reference standard. The single sharpest identity case in the dietary supplement industry, and a recurring §111.75 Warning Letter pattern when shortcuts are taken.

2,700 words · ~13 min read
On this page
  1. 01What botanical extract characterization covers
  2. 02Standardised vs full-spectrum extracts
  3. 03The botanical identity assay stack
  4. 04Drug-to-extract ratio (DER) — how full-spectrum is declared
  5. 05Common failure modes
  6. 06How V5 Ultimate handles botanical extract characterization
On this page · 6 sections
  1. 1What botanical extract characterization covers
  2. 2Standardised vs full-spectrum extracts
  3. 3The botanical identity assay stack
  4. 4Drug-to-extract ratio (DER) — how full-spectrum is declared
  5. 5Common failure modes
  6. 6How V5 Ultimate handles botanical extract characterization
AI · Explain it for MY operation

How does Botanical Extract Characterization apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01What botanical extract characterization covers

Botanical extract characterization is the multi-assay identity programme that establishes whether a received botanical-extract component lot matches the intended species, plant part, extraction process, and marker-compound or full-spectrum specification. It is the practical implementation of §111.75(a)(1)(i) identity testing for botanical components, which are inherently more variable and more subject to adulteration than synthetic chemicals.

One-sentence summary

Botanical extract identity = species + plant part + extraction solvent + marker-compound % (standardised) OR drug:extract ratio + HPTLC profile (full-spectrum); §111.75(a)(1)(i) mandates verification on every received lot, regardless of supplier COA.

02Standardised vs full-spectrum extracts

AttributeStandardised extractFull-spectrum extract
DeclarationMarker compound at declared % (e.g. 80% silymarin)Drug-to-extract ratio (DER, e.g. 4:1)
Identity testHPLC quantification of marker compoundHPTLC chromatographic fingerprint vs reference standard
ProsReproducible, marker-traceable, clinical-comparablePreserves matrix synergy, closer to traditional use, no marker-spiking risk
ConsRisk of marker-only spiking, loses non-marker activesHigher batch-to-batch variability, harder to standardise label claim
Typical usePremium clinical-positioned products (milk thistle, ginkgo)Traditional medicine positioning, multi-active botanicals (turmeric, ashwagandha root)
Marker-spiking trap

Standardised extract is vulnerable to economically-motivated adulteration where the supplier spikes a low-quality or adulterated material with isolated marker compound (e.g. adding pure silymarin to a sub-standard milk thistle base) to meet declared %. HPTLC + isotope-ratio MS + plant-specific minor-marker screening detect this; HPLC-only does not.

03The botanical identity assay stack

A defensible §111.75 identity programme for botanical extracts typically uses orthogonal methods:

  • Macroscopic — visual inspection of dried plant material (where applicable, pre-extraction). Confirms colour, particle size, texture. Cheapest and fastest first screen.
  • Microscopic — light microscopy of plant cells / starch grains / pollen / trichomes. References AHP, USP <2030>, or Ph. Eur. botanical monograph. Confirms anatomical match.
  • HPTLC (high-performance thin-layer chromatography) — chromatographic fingerprint pattern matched to a reference standard. AHP and USP monographs publish reference HPTLC patterns. Detects marker AND non-marker adulteration.
  • HPLC quantification — quantifies the marker compound % for standardised extracts. Confirms label-claim potency.
  • DNA barcoding — PCR-amplified species-specific gene region (ITS, rbcL, matK). Confirms species. Limited for processed extracts where DNA may be degraded.
  • Solvent residual — GC-MS for residual extraction solvent (ethanol, methanol, hexane, acetone). USP <467> sets ICH residual-solvent limits.
  • Heavy metals — ICP-MS for As, Pb, Cd, Hg per USP <2232>.
  • Pesticide residue — GC-MS / LC-MS for pesticide screen per USP <561>.
  • Microbial — plate count + pathogen screen per USP <2021>/<2022>/<2023>.
  • Foreign material — visual + sieving for contamination (insect fragments, rodent hair, foreign plant material).

04Drug-to-extract ratio (DER) — how full-spectrum is declared

Full-spectrum extracts are declared via DER (drug-to-extract ratio):

  • Native DER — ratio of dry plant material to the resulting extract before any added carrier or excipient. A 4:1 native DER means 4 kg dried plant produced 1 kg of pure extract.
  • Total DER — ratio after added carrier (maltodextrin, silicon dioxide, etc.). May be lower than native DER. Total DER should be disclosed alongside native if both apply.
  • Equivalency — '1 g of 4:1 native DER extract = 4 g of raw plant material' is a common label declaration that requires the DER to be accurate and reproducible.
  • Extraction solvent — must be disclosed alongside DER for meaningful interpretation. Water extract, 70% ethanol extract, methanol extract all yield different actives at the same DER.
DER without solvent is meaningless

A '10:1 extract' tells the buyer nothing without the extraction solvent. 10:1 hot-water extract of ashwagandha root has a different active-compound profile than 10:1 ethanol/water extract. Premium suppliers disclose both DER and solvent.

05Common failure modes

  • Single-assay identity — HPLC marker assay only, no orthogonal HPTLC or DNA. Misses marker-spiking adulteration. Most common §111.75 Warning Letter pattern for botanicals.
  • Supplier-COA acceptance — relying on supplier COA without independent identity verification. §111.75(a)(1)(i) does not permit this; identity test must be performed by the manufacturer on every received lot.
  • Wrong species — supplier ships related species (e.g. Echinacea purpurea instead of Echinacea angustifolia, or American ginseng vs Asian ginseng). Macroscopic and DNA barcoding detect; HPLC marker alone may not.
  • Wrong plant part — supplier ships leaf when root was ordered (cheaper, different active profile). Microscopic and chromatographic fingerprint detect.
  • Solvent residual exceeded — residual hexane / methanol in extract above ICH Q3C limits. Not detected without GC-MS solvent residual assay.
  • Adulteration with synthetic — pharmaceutical compound (e.g. PDE-5 inhibitor in 'natural' sexual-enhancement product) added to botanical extract. USP <2251> screening protocol.
  • Heavy-metal load from soil — turmeric, ginseng, and other root botanicals concentrate lead from soil; ICP-MS testing essential.
  • DER misrepresentation — supplier declares 10:1 native DER but extraction process actually yields 4:1; buyer pays 10:1 price for 4:1 material. Detectable via reference-extract comparison and total-solids assay.
  • Reference standard chain broken — HPTLC reference standard expires or is replaced with non-equivalent material; comparison becomes meaningless.

06How V5 Ultimate handles botanical extract characterization

Where botanical characterization shows up in V5

V5 tags every botanical component with species + plant part + extraction solvent + standardisation type + marker compound + DER, enforces multi-assay identity (HPLC + HPTLC + DNA + solvent residual + heavy metals) per §111.75 with single-assay reliance blocked, tracks reference-standard chain, and surfaces marker-spiking risk via fingerprint deviation from baseline.

  • Botanical component master: species (Latin binomial), plant part (root / leaf / aerial / seed / etc.), extraction solvent, DER (native + total), standardisation type (standardised / full-spectrum), marker compound, marker % spec.
  • Identity assay stack: per-component required assay list (HPLC + HPTLC + DNA + solvent residual + heavy metals + microbial); receipt-to-release workflow blocks at incomplete assay.
  • Reference standard register: per-marker reference standard with lot, expiration, COA, supplier, on-site location. Expiration triggers re-purchase + re-validation.
  • HPTLC fingerprint baseline: per-component baseline HPTLC pattern stored as image + Rf-value table; new lot compared to baseline; deviation above tolerance flags marker-spiking suspicion.
  • Supplier qualification: per-supplier history of identity-test pass rate; suppliers with declining pass rate or repeated adulteration findings flagged for re-audit or de-qualification.
  • DNA barcoding outsource: integrates with third-party DNA barcoding lab (Eurofins, Alkemist) with sample-submission workflow + result import.
  • BAPP / FDA adulterant intelligence: built-in subscription to American Botanical Council BAPP bulletins; if a known adulterant pattern is reported for a component species, V5 prompts re-verification of recent lots.
  • Reserve sample lifecycle: per §111.83/95 reserve sample collected from every received botanical lot + retained one year past expiration + auto-disposal workflow.
  • Per-SKU identity audit pack: complete identity dossier (HPLC + HPTLC + DNA + heavy metals + microbial + reserve sample location) per lot per SKU, generated as single PDF for FDA inspection / brand audit.

Frequently asked questions

Q.Is HPTLC mandatory?+

No — but it is the industry best-practice for botanical identity verification. HPLC marker alone is increasingly insufficient to defend against §111.75 Warning Letter scrutiny. AHP and USP monographs publish HPTLC reference patterns precisely because of marker-spiking risk.

Q.Is DNA barcoding required?+

Not regulatorily, but increasingly expected for premium products and for species pairs where adulteration is well-documented (Echinacea, ginseng, Hoodia). DNA barcoding limited for processed extracts where DNA may be degraded; macroscopic + HPTLC remain the work-horses.

Q.Can I rely on the supplier's COA for identity?+

No — §111.75(a)(1)(i) is explicit that the manufacturer must verify identity. Supplier COA is a useful input but cannot substitute for the manufacturer's identity test.

Q.What is the difference between standardised and concentrated extract?+

Standardised = marker compound at declared %. Concentrated = DER expressed (e.g. 10:1). Some products combine both (e.g. '10:1 extract standardised to 5% curcuminoids'). Always disclose both attributes for clarity.

Q.How do I detect marker-spiking?+

HPTLC chromatographic fingerprint vs reference standard; isotope-ratio MS for natural-vs-synthetic origin of the marker compound; AHP / BAPP bulletins for known supplier adulteration patterns; minor-marker screening (presence of non-marker plant compounds expected in the genuine extract).

Q.What is the role of organoleptic testing?+

Visual + taste + smell as preliminary screen — typically by a trained botanical specialist. Catches obvious adulteration cheaply. Cannot replace instrumental methods but is a useful first gate and is documented in many AHP monographs.

Q.Are USP monograph methods mandatory?+

Where a USP monograph exists for a botanical, the USP method is highly defensible. Where no USP monograph exists, AHP monograph or supplier-validated scientifically-valid method (§111.320) is acceptable; method validation evidence must be on file.

Primary sources

  • 21 CFR 111.75(a)(1)(i) — Component identity, purity, strength, composition (the 'identity test' obligation)
  • USP <565> — Botanical Extracts
  • USP <2030> — Articles of Botanical Origin
  • USP <2251> — Screening for Undeclared Drugs and Drug Analogues (anti-adulteration testing)
  • American Herbal Pharmacopoeia (AHP) — botanical monographs with HPTLC, HPLC, and microscopic identification references
  • American Botanical Council — Botanical Adulterants Prevention Program (BAPP) bulletins

Further reading

  • Identity testing 111.75(a)(1)(i)
    Parent regulatory obligation; this page is the botanical-specific deep dive.
  • Botanical authentication
    Orthogonal identity strategy (HPTLC + DNA + reference standard chain).
  • Heavy metals (supplements)
    Botanical extracts concentrate metals from soil; testing is parallel obligation.
  • Economically-motivated adulteration
    Marker-spiking and full-spectrum substitution are top EMA risks for botanicals.
  • Proprietary blend
    Botanical blends often disclosed only as proprietary; characterization still required internally.
Software that covers Botanical Extract Characterization
V5 Ultimate Dietary Supplements
Written for supplement contract manufacturers and brand owners tired of surviving FDA 483s on paper.
Talk to us about Botanical Extract Characterization

Want to see how Botanical Extract Characterization could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Inside V5
  • → Score your compliance gap — then download the validation pack.
  • → Document control — one version in force, every change signed and explained.
  • → QMS — quality records next to the work they concern.

Next step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse all features
V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal centre

© V5 Ultimate